Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4633611000168116 | budesonide + formoterol + glycopyrronium (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4633621000168111 | budesonide + glycopyrronium + formoterol | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
budesonide + glycopyrronium + formoterol | Is a | glycopyrronium | true | Inferred relationship | Some | ||
budesonide + glycopyrronium + formoterol | Is a | budesonide + formoterol | true | Inferred relationship | Some | ||
budesonide + glycopyrronium + formoterol | has intended active ingredient | glycopyrronium | true | Inferred relationship | Some | 2010947503 | |
budesonide + glycopyrronium + formoterol | has intended active ingredient | formoterol | true | Inferred relationship | Some | 67917061 | |
budesonide + glycopyrronium + formoterol | has intended active ingredient | budesonide | true | Inferred relationship | Some | 1338400818 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
budesonide 160 microgram/actuation + glycopyrronium 7.2 microgram/actuation + formoterol fumarate dihydrate 5 microgram/actuation inhalation, actuation | Is a | True | budesonide + glycopyrronium + formoterol | Inferred relationship | Some |
Reference Sets
Medicinal product reference set